EarningsQ4 2023 Earnings Report

Santhera Pharmaceuticals Holding (SPHDF) Q4 2023 Earnings Report

40 Followers

SPHDF Q4 2023 EPS Results

Actual EPS$8.75

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$2.56

Actual Revenue$119.75M

Expected Revenue$0.00

Beat/MissBeat by +$119.75M

YoY Revenue Growth+8033.69%

QuarterQ4 2023

Date04/25/2024

TimeBefore Open

Conference CallThursday, April 25, 2024

SPHDF Upcoming Earnings

Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.

SPHDF Q4 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 29, 2027	2026 (Q4)	- / -	-0.518	―
Sep 30, 2026	2026 (Q2)	0.20 / -1.81	-0.445	-305.41% (-1.36)
Apr 28, 2026	2025 (Q4)	-0.52 / -0.52	-0.891	41.89% (+0.37)
Sep 23, 2025	2025 (Q2)	-0.72 / -3.66	-1.625	-125.19% (-2.03)
Apr 29, 2025	2024 (Q4)	-0.89 / -0.89	8.752	-110.18% (-9.64)
Sep 12, 2024	2024 (Q2)	-1.13 / -1.63	-1.902	14.56% (+0.28)
Apr 25, 2024	2023 (Q4)	- / 8.75	-2.564	441.31% (+11.32)
Sep 07, 2023	2023 (Q2)	-1.90 / -1.90	-6.308	69.85% (+4.41)
Apr 27, 2023	2022 (Q4)	- / -2.56	-2.769	7.39% (+0.20)
Oct 31, 2022	2022 (Q2)	- / -6.31	-11.104	43.19% (+4.80)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed